Ls Investment Advisors Llc decreased its stake in Nisource Inc (NI) by 66.2% based on its latest 2019Q2 regulatory filing with the SEC. Ls Investment Advisors Llc sold 31,938 shares as the company’s stock rose 8.36% . The institutional investor held 16,305 shares of the public utilities company at the end of 2019Q2, valued at $470,000, down from 48,243 at the end of the previous reported quarter. Ls Investment Advisors Llc who had been investing in Nisource Inc for a number of months, seems to be less bullish one the $11.23B market cap company. The stock increased 0.37% or $0.11 during the last trading session, reaching $30.07. About 1.82 million shares traded. NiSource Inc. (NYSE:NI) has risen 15.44% since September 26, 2018 and is uptrending. It has outperformed by 15.44% the S&P500. Some Historical NI News: 13/03/2018 - Vectren draws three suitors in second round; 02/05/2018 - NiSource Sees Dividend Growth of 5%-7% Each Yr Through 2020; 16/03/2018 - Columbia Gas of Pennsylvania Files to Recover Investment in Replacing and Upgrading Aging Infrastructure; 14/03/2018 - Glancy Prongay & Murray LLP Commences Investigation on Behalf of NiSource Inc. Investors (Nl); 04/04/2018 - NISOURCE HALTS DATA EXCHANGE WITH PIPELINES AFTER CYBER ATTACK; 23/04/2018 - Agreement Reached in NIPSCO’s Proposal to Modify Natural Gas Rates; 19/04/2018 - NISOURCE - UNDER AGREEMENT, CO BORROWED INITIAL TRANCHE OF $150 MLN ON APRIL 18, MAY BORROW SECOND TRANCHE OF UP TO $450 MLN PRIOR TO JUNE 15, 2018; 02/05/2018 - NiSource 1Q Net $276.1M; 02/05/2018 - NiSource 1Q Rev $1.03B; 02/05/2018 - NiSource 1Q EPS 82c

Optimum Investment Advisors decreased its stake in Abbvie Inc (ABBV) by 24.29% based on its latest 2019Q2 regulatory filing with the SEC. Optimum Investment Advisors sold 9,028 shares as the company’s stock declined 15.55% . The institutional investor held 28,143 shares of the major pharmaceuticals company at the end of 2019Q2, valued at $2.05M, down from 37,171 at the end of the previous reported quarter. Optimum Investment Advisors who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $106.58 billion market cap company. The stock decreased 1.18% or $0.86 during the last trading session, reaching $72.09. About 5.68 million shares traded. AbbVie Inc. (NYSE:ABBV) has declined 27.15% since September 26, 2018 and is downtrending. It has underperformed by 27.15% the S&P500. Some Historical ABBV News: 22/03/2018 - ABBVIE REPORTS RESULTS FROM PHASE 2 STUDY EVALUATING ROVALPITUZ; 19/04/2018 - Good news for $GLPG $GILD $ABBV is that FDA sees thrombosis as a unique issue with $INCY $LLY baricitinib and not seen with other JAKi; 20/04/2018 - Jennison Adds Hill-Rom, Exits Cooper Cos, Cuts AbbVie; 06/04/2018 - Incyte’s new immunotherapy drug epacadostat failed to work in conjunction with Merck’s blockbuster melanoma drug Keytruda; 25/04/2018 - Protocols: AbbVie advances its two star pipeline therapies, filing BLA for risankizumab and posting promising data for upadacitinib $ABBV; 24/03/2018 - ImmunoGen Presents Data from FORWARD II Assessment of Mirvetuximab Soravtansine in Combination with Pembrolizumab at the Societ; 16/05/2018 - Merck:Evidence Continues to Support the Role of KEYTRUDA as a Foundational Treatment for Many Types of Cancer; 17/05/2018 - SYNDAX: ENTINOSTAT/KEYTRUDA TRIAL SUGGESTS `ENHANCED BENEFIT`; 10/04/2018 - ABBVIE INC - REGULATORY SUBMISSIONS FOR ELAGOLIX IN UTERINE FIBROIDS REMAIN ON TRACK; 31/05/2018 - AbbVie to Present New Data from Several Investigational Studies of Venetoclax as Monotherapy or in Combination for the Management of a Number of Difficult-to-Treat Blood Cancers at 23rd European Hematology Association (EHA) Annual Congress

Ls Investment Advisors Llc, which manages about $1.86 billion and $1.65 billion US Long portfolio, upped its stake in Wal (NYSE:WMT) by 10,922 shares to 77,691 shares, valued at $8.58 million in 2019Q2, according to the filing. It also increased its holding in Hormel Foods (NYSE:HRL) by 16,575 shares in the quarter, for a total of 124,307 shares, and has risen its stake in Wells Fargo & Co (NYSE:WFC).

Analysts await NiSource Inc. (NYSE:NI) to report earnings on November, 7. They expect $0.04 earnings per share, down 60.00% or $0.06 from last year’s $0.1 per share. NI’s profit will be $14.93 million for 187.94 P/E if the $0.04 EPS becomes a reality. After $0.05 actual earnings per share reported by NiSource Inc. for the previous quarter, Wall Street now forecasts -20.00% negative EPS growth.

More notable recent NiSource Inc. (NYSE:NI) news were published by: Finance.Yahoo.com which released: “Here’s What Hedge Funds Think About NiSource Inc. (NI) - Yahoo Finance” on June 18, 2019, also Prnewswire.com with their article: “NiSource Statement on NTSB Investigation - PRNewswire” published on September 24, 2019, Streetinsider.com published: “NiSource (NI) Issues Statement on NTSB Investigation - StreetInsider.com” on September 24, 2019. More interesting news about NiSource Inc. (NYSE:NI) were released by: Finance.Yahoo.com and their article: “Read This Before Judging NiSource Inc.’s (NYSE:NI) ROE - Yahoo Finance” published on August 13, 2019 as well as Finance.Yahoo.com‘s news article titled: “Have Insiders Been Selling NiSource Inc. (NYSE:NI) Shares This Year? - Yahoo Finance” with publication date: May 17, 2019.

Investors sentiment decreased to 1.25 in 2019 Q2. Its down 0.05, from 1.3 in 2019Q1. It is negative, as 25 investors sold NI shares while 114 reduced holdings. 44 funds opened positions while 130 raised stakes. 329.34 million shares or 2.95% less from 339.36 million shares in 2019Q1 were reported. State Of Tennessee Treasury Department accumulated 85,975 shares. Engineers Gate Manager Limited Partnership has 0.07% invested in NiSource Inc. (NYSE:NI). Landscape Cap Management Ltd has 0.03% invested in NiSource Inc. (NYSE:NI) for 12,379 shares. Hrt Fincl Limited Liability owns 12,162 shares. Financial Bank holds 15,180 shares or 0% of its portfolio. Amp Cap Invsts Ltd holds 0.2% of its portfolio in NiSource Inc. (NYSE:NI) for 1.24M shares. Guggenheim Ltd Com reported 134,518 shares. Qci Asset reported 500 shares. Chevy Chase stated it has 311,441 shares or 0.04% of all its holdings. Moreover, Private Advisor Ltd Liability has 0.02% invested in NiSource Inc. (NYSE:NI) for 29,044 shares. Captrust Fincl, North Carolina-based fund reported 1,430 shares. Hsbc Public Limited Company has 266,013 shares for 0.01% of their portfolio. Moody Financial Bank Tru Division accumulated 159,663 shares. 21,200 are owned by Cohen Cap. Bancorporation Of America De holds 1.72 million shares.

Investors sentiment increased to 1.16 in Q2 2019. Its up 0.33, from 0.83 in 2019Q1. It is positive, as 67 investors sold ABBV shares while 513 reduced holdings. 129 funds opened positions while 542 raised stakes. 950.66 million shares or 1.26% less from 962.74 million shares in 2019Q1 were reported. Jupiter Asset Mgmt owns 204,365 shares. Argent Trust reported 109,722 shares stake. Moors & Cabot reported 35,629 shares. Palisade Cap Management Limited Liability Company Nj has invested 0.06% in AbbVie Inc. (NYSE:ABBV). Schafer Cullen Capital Mgmt Inc holds 0% or 4,240 shares in its portfolio. Mastrapasqua Asset Mgmt holds 0.16% in AbbVie Inc. (NYSE:ABBV) or 11,727 shares. Moreover, Utah Retirement Systems has 0.39% invested in AbbVie Inc. (NYSE:ABBV). Wesbanco Retail Bank holds 0.23% or 65,291 shares in its portfolio. Peddock Capital Llc has 3,350 shares for 0.13% of their portfolio. Albion Financial Group Inc Ut accumulated 5,594 shares. Virginia-based Of Virginia Va has invested 0.1% in AbbVie Inc. (NYSE:ABBV). Moreover, Df Dent And Com Incorporated has 0.01% invested in AbbVie Inc. (NYSE:ABBV). Fort Point Prtn Limited Com invested in 2.28% or 79,215 shares. Markston Intll Limited Liability Company reported 137,468 shares. Altavista Wealth has 0.11% invested in AbbVie Inc. (NYSE:ABBV) for 4,747 shares.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Finance.Yahoo.com which released: “Notable Insider Buys In The Past Week: AbbVie, Kraft Heinz And More - Yahoo Finance” on September 22, 2019, also 247Wallst.com with their article: “Top Analyst Upgrades and Downgrades: AbbVie, Ally, Anthem, Caterpillar, CVS, Deere, Oracle, PayPal, Rite Aid, Square, Uber, UnitedHealth and More - 24/7 Wall St.” published on September 12, 2019, Seekingalpha.com published: “AbbVie Is One Of The Best High-Yield Stocks You Can Buy Right Now - Seeking Alpha” on September 23, 2019. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Finance.Yahoo.com and their article: “The Week Ahead In Biotech: Spotlight On ESMO Conference - Yahoo Finance” published on September 22, 2019 as well as Fool.com‘s news article titled: “How Will Johnson & Johnson’s Opioid Case Ruling Impact Big Pharma Stocks? - The Motley Fool” with publication date: September 05, 2019.